NO20091627L - Procedure for Identifying Potential Biomarkers and Drug Templates in Brain Plasticity-Related Disorders - Google Patents

Procedure for Identifying Potential Biomarkers and Drug Templates in Brain Plasticity-Related Disorders

Info

Publication number
NO20091627L
NO20091627L NO20091627A NO20091627A NO20091627L NO 20091627 L NO20091627 L NO 20091627L NO 20091627 A NO20091627 A NO 20091627A NO 20091627 A NO20091627 A NO 20091627A NO 20091627 L NO20091627 L NO 20091627L
Authority
NO
Norway
Prior art keywords
related disorders
potential biomarkers
brain plasticity
procedure
identifying potential
Prior art date
Application number
NO20091627A
Other languages
Norwegian (no)
Inventor
Abhay Sharma
Priyanka Singh
Farhan, Md
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of NO20091627L publication Critical patent/NO20091627L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen angår identifikasjon av potensielle biomarkører og legemiddelmål i hjerneplastisitet relaterte forstyrrelser. Særlig beskriver oppfinnelsen en systemnivåmodell for hjerneplastisitetsrelaterte forstyrrelser i bananfluen Drosophila melanogaster, som derved identifiserer potensielle biomarkører og legemiddelmål i epileptogenese og assosierte tilstander. Oppfinnelsen tilveiebringer også en måte for å screene terapeutiske midler mot epilepsi og relaterte forstyrrelser ved anvendelse av genekspresjonsprofilering i Drosophila.The invention relates to the identification of potential biomarkers and drug targets in brain plasticity related disorders. In particular, the invention discloses a system level model for brain plasticity-related disorders in the banana fly Drosophila melanogaster, thereby identifying potential biomarkers and drug targets in epileptogenesis and associated conditions. The invention also provides a means for screening therapeutic agents against epilepsy and related disorders using gene expression profiling in Drosophila.

NO20091627A 2006-10-05 2009-04-23 Procedure for Identifying Potential Biomarkers and Drug Templates in Brain Plasticity-Related Disorders NO20091627L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2193DE2006 2006-10-05
PCT/IN2007/000452 WO2008041244A2 (en) 2006-10-05 2007-10-01 A method for the identification of potential biomarkers and drug targets in brain plasticity related disorders

Publications (1)

Publication Number Publication Date
NO20091627L true NO20091627L (en) 2009-07-02

Family

ID=39198212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091627A NO20091627L (en) 2006-10-05 2009-04-23 Procedure for Identifying Potential Biomarkers and Drug Templates in Brain Plasticity-Related Disorders

Country Status (3)

Country Link
EP (1) EP2076608A2 (en)
NO (1) NO20091627L (en)
WO (1) WO2008041244A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108977549B (en) * 2018-07-04 2021-01-15 中国农业大学 Primer pair for detecting expression quantity of CG5210 gene of fruit fly

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291739B1 (en) * 2000-03-24 2001-09-18 Council Of Scientific And Industrial Research Method for screening of potential anti-epileptic drugs using a Drosophila melanogaster model

Also Published As

Publication number Publication date
WO2008041244B1 (en) 2008-10-09
WO2008041244A3 (en) 2008-07-31
WO2008041244A2 (en) 2008-04-10
EP2076608A2 (en) 2009-07-08

Similar Documents

Publication Publication Date Title
DE602005025106D1 (en) METHODS OF MEDICATION REVIEW BASED ON VITRO DIFFERENTIATED CELLS
ATE397676T1 (en) IDENTIFICATION AND USE OF MIRNAS FOR DIFFERENTIATION OF MYELOGENE LEUKEMIA CELLS
ATE390925T1 (en) USE OF SUBSTITUTED QUINOLINE DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT MYCOBACTERIAL DISEASES
WO2009132656A3 (en) Crystal structure of human sortilin and uses thereof for identifying ligands to sortilin
DE602005020209D1 (en) System for the evaluation of cardiac disorders
EP2227725A4 (en) Clinical applications of neuropsychological pattern analysis and modeling
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
ATE457773T1 (en) AGENTS FOR THE FUNCTIONAL RESTORATION OF A DAMAGED NERVOUS SYSTEM
ATE551432T1 (en) GENES AND PATHWAYS EXPRESSED DIFFERENTLY IN MANIC-DEPRESSIVE DISEASE AND/OR SEVERE DEPRESSIVE DISEASE
ATE512948T1 (en) BIPHENYL-SULFONYL AND PHENYL-HETEROARYL-SULFONYL MODULATORS OF THE HISTAMINE H3 RECEPTOR FOR THE TREATMENT OF RELATED DISEASES
DE602005013895D1 (en) Device for the production of tire components.
ATE465986T1 (en) SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES FOR THE TREATMENT OF EYE HYPERTENSION
WO2008019052A3 (en) Methods and compositions for identifying biomarkers
DE502006001195D1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF ANALGETICS
AT503967A3 (en) DEVICE FOR PRODUCING SHAPED PARTS
ATE513929T1 (en) GENES AFFECTING HUMAN MEMORY PERFORMANCE
DE602006018461D1 (en) GALK1S AS PTEN / ACT WAY MODIFICATORS
NO20091627L (en) Procedure for Identifying Potential Biomarkers and Drug Templates in Brain Plasticity-Related Disorders
EA201070496A1 (en) CARBON-ASSOCIATED γ-SECRETASE MODULATORS
WO2006009962A3 (en) Acacs as modifiers of the igf pathway and methods of use
WO2005016279A3 (en) Melks as modifiers of the rac pathway and methods of use
ATE446757T1 (en) 1-Ä2H-1-BENZOPYRAN-2-ONE-8-YLÜ-PIPERAZINE DERIVATIVE FOR THE TREATMENT OF MOVEMENT DISORDERS
BRPI0410975A (en) crystalline form of trypanosoma cruzi praca (proline) proline racemase, composition, methods for making a crystalline form of prostate and for identifying a substance that can bind to the prostate and consequently affect the biological activity of prostate, substance, device for performing the method, method for designing a molecule that affects the biological activity of tcpraca, and, molecule
ATE494551T1 (en) C20ORF23 AS A MODIFIER OF THE IGFR PATHWAY AND METHOD OF USE
WO2006036613A3 (en) Mracs as modifiers of the rac pathway and methods of use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application